‘Getting the dose right’ – A blog by Dr Jan Hansel
Author: Dr Jan Hansel
As part of World Antimicrobial Awareness Week (18 to 24 November 2023), Dr Jan Hansel discusses the importance of therapeutic drug monitoring in limiting the development of antimicrobial resistance (AMR) and the new Manchester BRC-funded TDM-TIME study which he is leading.
Continue reading full article: ‘Getting the dose right’ – A blog by Dr Jan Hansel
Disturbed sleep may partially explain Long COVID breathlessness, find researchers
A major UK study has discovered that the disturbed sleep patterns in patients hospitalised with COVID-19 was likely to be a driver of breathlessness.
Continue reading full article: Disturbed sleep may partially explain Long COVID breathlessness, find researchers
Malfunctioning immune cell behaviour could be drug target in Long Covid
Greater Manchester researchers have shown for the first time that malfunctioning behaviour of a type of immune cell is linked to specific symptoms of Long COVID.
Continue reading full article: Malfunctioning immune cell behaviour could be drug target in Long Covid
Manchester BRC researcher receives prestigious international early career research honour
A researcher at Manchester BRC has won a celebrated international prize, in recognition for his work in respiratory (breathing) research.
Continue reading full article: Manchester BRC researcher receives prestigious international early career research honour
‘World-first’ graphene-based test could rapidly detect patients’ need for antibiotic treatment
Research into a new generation of a graphene-based diagnostic test – which could identify patients who need antibiotics in minutes, instead of hours – will be delivered in Manchester.
Continue reading full article: ‘World-first’ graphene-based test could rapidly detect patients’ need for antibiotic treatment
Manchester BRC researchers receive prestigious national appointments
Three researchers from Manchester Biomedical Research Centre (BRC) have been appointed Senior Investigators by the National Institute for Health Research (NIHR).
Continue reading full article: Manchester BRC researchers receive prestigious national appointments
Global trials show drug eases symptoms of chronic cough
The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.
Continue reading full article: Global trials show drug eases symptoms of chronic cough
COVID-19 study finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised patients
Professor Paul Dark, Non-fungal Infections Programme Lead, is one of the authors of the paper “Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19,” recently published in JAMA.
Continue reading full article: COVID-19 study finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised patients